Adjuvant therapy in node-negative breast cancer. A panel discussion.
McGuire
W L
WL
University of Texas Health Science Center, San Antonio 78284.
Abeloff
M D
MD
Fisher
B
B
Glick
J H
JH
Henderson
I C
IC
Osborne
C K
CK
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004992:Ethics, Medical; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D011379:Prognosis; D011960:Receptors, Estrogen / Q000187:drug effects; D012106:Research; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011960:Receptors, Estrogen; D013629:Tamoxifen